166 related articles for article (PubMed ID: 37494811)
1. PAIP 2020: Microsatellite instability prediction in colorectal cancer.
Kim K; Lee K; Cho S; Kang DU; Park S; Kang Y; Kim H; Choe G; Moon KC; Lee KS; Park JH; Hong C; Nateghi R; Pourakpour F; Wang X; Yang S; Jahromi SAF; Khani A; Kim HR; Choi DH; Han CH; Kwak JT; Zhang F; Han B; Ho DJ; Kang GH; Chun SY; Jeong WK; Park P; Choi J
Med Image Anal; 2023 Oct; 89():102886. PubMed ID: 37494811
[TBL] [Abstract][Full Text] [Related]
2. PPsNet: An improved deep learning model for microsatellite instability high prediction in colorectal cancer from whole slide images.
Lou J; Xu J; Zhang Y; Sun Y; Fang A; Liu J; Mur LAJ; Ji B
Comput Methods Programs Biomed; 2022 Oct; 225():107095. PubMed ID: 36057226
[TBL] [Abstract][Full Text] [Related]
3. Is There a Role for Programmed Death Ligand-1 Testing and Immunotherapy in Colorectal Cancer With Microsatellite Instability? Part I-Colorectal Cancer: Microsatellite Instability, Testing, and Clinical Implications.
Marginean EC; Melosky B
Arch Pathol Lab Med; 2018 Jan; 142(1):17-25. PubMed ID: 29144791
[TBL] [Abstract][Full Text] [Related]
4. Clinical Significance and Prognostic Relevance of Microsatellite Instability in Sporadic Colorectal Cancer Patients.
Copija A; Waniczek D; Witkoś A; Walkiewicz K; Nowakowska-Zajdel E
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28067827
[TBL] [Abstract][Full Text] [Related]
5. PAIP 2019: Liver cancer segmentation challenge.
Kim YJ; Jang H; Lee K; Park S; Min SG; Hong C; Park JH; Lee K; Kim J; Hong W; Jung H; Liu Y; Rajkumar H; Khened M; Krishnamurthi G; Yang S; Wang X; Han CH; Kwak JT; Ma J; Tang Z; Marami B; Zeineh J; Zhao Z; Heng PA; Schmitz R; Madesta F; Rösch T; Werner R; Tian J; Puybareau E; Bovio M; Zhang X; Zhu Y; Chun SY; Jeong WK; Park P; Choi J
Med Image Anal; 2021 Jan; 67():101854. PubMed ID: 33091742
[TBL] [Abstract][Full Text] [Related]
6. Does microsatellite instability predict the efficacy of adjuvant chemotherapy in colorectal cancer? A systematic review with meta-analysis.
Des Guetz G; Schischmanoff O; Nicolas P; Perret GY; Morere JF; Uzzan B
Eur J Cancer; 2009 Jul; 45(10):1890-6. PubMed ID: 19427194
[TBL] [Abstract][Full Text] [Related]
7. Microsatellite instability: a predictive marker in metastatic colorectal cancer?
Des Guetz G; Uzzan B; Nicolas P; Schischmanoff O; Morere JF
Target Oncol; 2009 Jan; 4(1):57-62. PubMed ID: 19343302
[TBL] [Abstract][Full Text] [Related]
8. Combined microsatellite instability and BRAF gene status as biomarkers for adjuvant chemotherapy in stage III colorectal cancer.
Ooki A; Akagi K; Yatsuoka T; Asayama M; Hara H; Takahashi A; Kakuta M; Nishimura Y; Yamaguchi K
J Surg Oncol; 2014 Dec; 110(8):982-8. PubMed ID: 25154726
[TBL] [Abstract][Full Text] [Related]
9. Rate of dissemination and prognosis in early and advanced stage colorectal cancer based on microsatellite instability status: systematic review and meta-analysis.
Toh JWT; Phan K; Reza F; Chapuis P; Spring KJ
Int J Colorectal Dis; 2021 Aug; 36(8):1573-1596. PubMed ID: 33604737
[TBL] [Abstract][Full Text] [Related]
10. Current status on microsatellite instability, prognosis and adjuvant therapy in colon cancer: A nationwide survey of medical oncologists, colorectal surgeons and gastrointestinal pathologists.
Toh JWT; Mahajan H; Chapuis P; Spring K
Cancer Rep (Hoboken); 2021 Feb; 4(1):e1297. PubMed ID: 33030308
[TBL] [Abstract][Full Text] [Related]
11. [Predictive and prognostic value of MSI phenotype in adjuvant colon cancer: Who and how to treat?].
Zaanan A; Taieb J
Bull Cancer; 2019 Feb; 106(2):129-136. PubMed ID: 30527814
[TBL] [Abstract][Full Text] [Related]
12. Validation of computational determination of microsatellite status using whole exome sequencing data from colorectal cancer patients.
Johansen AFB; Kassentoft CG; Knudsen M; Laursen MB; Madsen AH; Iversen LH; Sunesen KG; Rasmussen MH; Andersen CL
BMC Cancer; 2019 Oct; 19(1):971. PubMed ID: 31638937
[TBL] [Abstract][Full Text] [Related]
13. Correlations between microsatellite instability, ERCC1/XRCC1 polymorphism and clinical characteristics, and FOLFOX adjuvant chemotherapy effect of colorectal cancer patients.
Zhang L; Zhao J; Yu B; Song X; Sun G; Han L; Wang L; Dong S
Cancer Genet; 2017 Dec; 218-219():51-57. PubMed ID: 29153096
[TBL] [Abstract][Full Text] [Related]
14. Microsatellite instability and colorectal cancer prognosis.
Benatti P; Gafà R; Barana D; Marino M; Scarselli A; Pedroni M; Maestri I; Guerzoni L; Roncucci L; Menigatti M; Roncari B; Maffei S; Rossi G; Ponti G; Santini A; Losi L; Di Gregorio C; Oliani C; Ponz de Leon M; Lanza G
Clin Cancer Res; 2005 Dec; 11(23):8332-40. PubMed ID: 16322293
[TBL] [Abstract][Full Text] [Related]
15. High-frequency microsatellite instability predicts better chemosensitivity to high-dose 5-fluorouracil plus leucovorin chemotherapy for stage IV sporadic colorectal cancer after palliative bowel resection.
Liang JT; Huang KC; Lai HS; Lee PH; Cheng YM; Hsu HC; Cheng AL; Hsu CH; Yeh KH; Wang SM; Tang C; Chang KJ
Int J Cancer; 2002 Oct; 101(6):519-25. PubMed ID: 12237891
[TBL] [Abstract][Full Text] [Related]
16. Methylation and microsatellite status and recurrence following adjuvant FOLFOX in colorectal cancer.
Han SW; Lee HJ; Bae JM; Cho NY; Lee KH; Kim TY; Oh DY; Im SA; Bang YJ; Jeong SY; Park KJ; Park JG; Kang GH; Kim TY
Int J Cancer; 2013 May; 132(9):2209-16. PubMed ID: 23034738
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological predictors of benefit from adjuvant chemotherapy for stage C colorectal cancer: Microsatellite unstable cases benefit.
Thomas ML; Hewett PJ; Ruszkiewicz AR; Moore JW
Asia Pac J Clin Oncol; 2015 Dec; 11(4):343-51. PubMed ID: 26471980
[TBL] [Abstract][Full Text] [Related]
18. Microsatellite instability and survival after adjuvant chemotherapy among stage II and III colon cancer patients: results from a population-based study.
Alwers E; Jansen L; Bläker H; Kloor M; Tagscherer KE; Roth W; Boakye D; Herpel E; Grüllich C; Chang-Claude J; Brenner H; Hoffmeister M
Mol Oncol; 2020 Feb; 14(2):363-372. PubMed ID: 31816156
[TBL] [Abstract][Full Text] [Related]
19. Microsatellite instability is a predictive marker for survival benefit from adjuvant chemotherapy in a population-based series of stage III colorectal carcinoma.
Elsaleh H; Iacopetta B
Clin Colorectal Cancer; 2001 Aug; 1(2):104-9. PubMed ID: 12445368
[TBL] [Abstract][Full Text] [Related]
20. Microsatellite instability did not predict individual survival of unselected patients with colorectal cancer.
Lamberti C; Lundin S; Bogdanow M; Pagenstecher C; Friedrichs N; Büttner R; Sauerbruch T
Int J Colorectal Dis; 2007 Feb; 22(2):145-52. PubMed ID: 16724208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
